Sagimet Biosciences Inc.
SGMT
$5.14
-$0.07-1.34%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -51.04M | -57.67M | -59.38M | -57.11M | -45.57M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 6.44M | 5.93M | 4.96M | 4.55M | 4.18M |
| Change in Net Operating Assets | -1.05M | 6.90M | 195.00K | 1.80M | -1.05M |
| Cash from Operations | -45.65M | -44.84M | -54.23M | -50.76M | -42.44M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 4.56M | 48.00K | 597.00K | -61.27M | -61.68M |
| Cash from Investing | 4.56M | 48.00K | 597.00K | -61.27M | -61.68M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 275.00K | 275.00K | 1.00K | 0.00 | 105.86M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 0.00 | 0.00 | -27.00K | -1.05M |
| Cash from Financing | 275.00K | 275.00K | 1.00K | -27.00K | 104.82M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -40.82M | -44.52M | -53.63M | -112.06M | 701.00K |